← Leaderboards
Jennifer R King
University Of Alabama At Birmingham
$722,454
Attributed
$722,454
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $177.7K · FY2008–12$200K$150K$100K$50K$0
'08
'09
'10
'11
'12
Funding mix
By agency
NIH$722,454 · 1
By mechanism
K23$722,454 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Alabama At Birmingham
Same institution · by research overlap
- Robert B. Diasio$27,640,960
- Benjamin H Chi$27,017,926
- Roger B Fillingim$35,218,319
- Ronnie M Gravett$877,454
- Etty N. Benveniste$18,164,533
Others in their field
Top investigators on “Drug Kinetics”
- Leonard Freedman · Leidos Biomedical Research, Inc.$241,865,009
- Sharon A Nachman · Johns Hopkins University$194,646,762
- Carol Nesel · Westat$147,274,423
- Barbara Driver · Westat, Inc.$103,746,400
- Ronald T Mitsuyasu · University Of California Los Angeles$99,239,507
- Lynn Briscoe · Leidos Biomedical Research, Inc.$93,714,869
Research focus
Drug KineticsEmtricitabineDrug InteractionsAccountingAnti-Retroviral AgentsAcquired Immunodeficiency SyndromeAffectBaseCareerAlabamaCaringCenters For Disease Control And Prevention (U.S.)Antiretroviral TherapyClinical InvestigatorClinically RelevantAtazanavirClinical ResearchClinical TrialsComputer SoftwareDesignDoseDrug DevelopmentDrug ExposureEnrollment
Grant awards (7)
Impact of Menstrual Cycle on Antiretroviral Pharmacokinetics$127,765
K23 · FY2012 · AI · contact PI
Impact of Menstrual Cycle on Antiretroviral Pharmacokinetics$127,765
K23 · FY2011 · AI · contact PI
Impact of Menstrual Cycle on Antiretroviral Pharmacokinetics$127,765
K23 · FY2010 · AI · contact PI
Impact of Menstrual Cycle on Antiretroviral Pharmacokinetics$36,369
K23 · FY2010 · AI · contact PI
Impact of Menstrual Cycle on Antiretroviral Pharmacokinetics$127,665
K23 · FY2009 · AI · contact PI
Impact of Menstrual Cycle on Antiretroviral Pharmacokinetics$50,000
K23 · FY2009 · AI · contact PI
Impact of Menstrual Cycle on Antiretroviral Pharmacokinetics$125,125
K23 · FY2008 · AI · contact PI